Key facts
| Price (PPV) | 380 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | cétrorélix |
| Class | Pituitary and hypothalamic hormones |
| ATC code | H01CC02 |
| Manufacturer | PROMOPHARM (HIKMA) |
| Presentation | Boite de 1 |
| Nature | Médicament |
| Hospital price | 252 MAD |
| Data collected on | 9/8/2026 |
Indications
Prévention de l’ovulation prématurée chez les patientes incluses dans un protocole de stimulation ovarienne contrôlée, suivie de prélèvement d’ovocytes et de techniques de reproduction assistée. Dans les études cliniques, Cetrotide a été associé à la gonadotrophine de femme ménopausée (HMG). Cependant, l’expérience plus réduite acquise avec l’hormone folliculo-stimulante (FSH) recombinante suggère une efficacité équivalente
Find an open pharmacy
On-call pharmacies near you
About Cetrotide 0.25 mg
Cetrotide 0.25 mg belongs to the pituitary and hypothalamic hormones therapeutic class. In Morocco, this drug is marketed by PROMOPHARM (HIKMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Cetrotide 0.25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Cetrotide 0.25 mg
Answers to common questions from Moroccan patients about this drug.